Early Vedolizumab as First-Line for Immune-Related Colitis Therapy Trial
Clinical trial NCT06841705 · RECRUITING
Trial details
- NCT number
- NCT06841705
- Sponsor
- Shilpa Grover, MD, MPH
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-15
- Primary completion
- 2026-07-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.